Lord Abbett Micro Cap Growth Fund (LCMGX)
| Fund Assets | 186.37M |
| Expense Ratio | 2.13% |
| Min. Investment | $1,500 |
| Turnover | 122.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 23.01 |
| YTD Return | 1.31% |
| 1-Year Return | 12.99% |
| 5-Year Return | -17.94% |
| 52-Week Low | 15.30 |
| 52-Week High | 24.65 |
| Beta (5Y) | n/a |
| Holdings | 73 |
| Inception Date | Aug 28, 2020 |
About LCMGX
Lord Abbett Micro Cap Growth Fund Class C is an actively managed mutual fund that focuses on seeking long-term capital appreciation by investing primarily in the equity securities of micro-cap and small-cap U.S. companies. The fund is structured to maintain at least 80% of its net assets in stocks of micro-cap firms, which are generally characterized by smaller market capitalizations and the potential for dynamic growth. With a diversified portfolio currently consisting of 73 holdings across sectors like communication services, industrials, health care, information technology, and consumer discretionary, the fund captures a broad cross-section of emerging business opportunities. Notable holdings as of May 2025 include Argan Inc, Grindr Inc, Paymentus Holdings Inc, and Universal Technical Institute Inc, highlighting its exposure to innovative and growth-oriented companies. The fund’s approach positions it to access segments of the market that are often less represented in larger-cap funds, providing a unique role in fostering early-stage corporate development. It is overseen by an experienced investment team and caters to investors seeking diversified exposure to the U.S. micro-cap growth sector with annual dividend distributions and a net asset base of over $170 million as of May 2025.
Performance
LCMGX had a total return of 12.99% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.05%.
Top 10 Holdings
29.03% of assets| Name | Symbol | Weight |
|---|---|---|
| Cogent Biosciences, Inc. | COGT | 4.45% |
| Tarsus Pharmaceuticals, Inc. | TARS | 3.40% |
| Adaptive Biotechnologies Corporation | ADPT | 3.40% |
| Argan, Inc. | AGX | 3.28% |
| GeneDx Holdings Corp. | WGS | 2.76% |
| Celcuity Inc. | CELC | 2.64% |
| TeraWulf Inc. | WULF | 2.43% |
| Artivion, Inc. | AORT | 2.31% |
| Applied Digital Corporation | APLD | 2.23% |
| Willdan Group, Inc. | WLDN | 2.13% |